MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Patient Engagement in Parkinson’s Research: A Comparison of Attitudes and Impact in the UK and the US

V. Todaro, C. Nolan, K. Schroeder, I. Abbey-Vital, M. Feeney (New York, NY, USA)

Meeting: 2017 International Congress

Abstract Number: 1382

Keywords: Parkinsonism

Session Information

Date: Thursday, June 8, 2017

Session Title: Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To compare and contrast the attitudes and perceived impact of patient engagement on Parkinson’s research among patients, researchers and study sponsors in the UK and US. 

Background: There is growing evidence that the relevance and quality of health services and clinical research is enhanced when patients partner with scientists in study design, implementation, management and results dissemination. Funders, ethics committees and regulators are increasingly asking for evidence of patient and public involvement.  Scientific journals are beginning to ask researchers to report on patient engagement when publishing. Parkinson’s is a complex disease with many domains including physical, emotional, social and cognitive. Because of this, it is imperative that the Parkinson’s research community work alongside patients and carers to ensure the best quality and most relevant research is conducted. Parkinson’s UK and the Parkinson’s Disease Foundation, a division of the Parkinson’s Foundation, have lead initiatives to facilitate partnerships among patients and researchers. These programmes have trained and supported 280 patient advocates in the US and over 100 patient volunteers in the UK. The programmes also provide consultation and support to researchers who wish to collaborate with patients. To date, there has been no comparative analysis of attitudes toward and impact of patient engagement among Parkinson’s programs based in two separate countries with organizational and systematic similarities and differences. 

Methods: An online survey will be administered to assess attitudes and perceived impact of patient engagement among: 1. PDF (US) and Parkinson UK volunteers engaged in research advocacy; 2. US and UK academic researchers who have partnered with patients; and 3. US and UK industry sponsors who have partnered with patients. 

Results: Analysis of the online survey results will be conducted to identify differences in the attitudes and perceived impact of public engagement in the groups identified.

Conclusions: Findings from non-comparative organizational surveys indicate that patients, academic researchers and industry sponsors have different attitudes and perceptions of impact of public engagement in Parkinson’s. This survey aims to identify and quantify these differences so as to develop more effective patient engagement mechanisms.

To cite this abstract in AMA style:

V. Todaro, C. Nolan, K. Schroeder, I. Abbey-Vital, M. Feeney. Patient Engagement in Parkinson’s Research: A Comparison of Attitudes and Impact in the UK and the US [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/patient-engagement-in-parkinsons-research-a-comparison-of-attitudes-and-impact-in-the-uk-and-the-us/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/patient-engagement-in-parkinsons-research-a-comparison-of-attitudes-and-impact-in-the-uk-and-the-us/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley